Chairperson(s) : Sung Nim Han (Seoul National University, Republic of Korea), Myoung Sook Lee (Sungshin Women's University, Republic of Korea)
Panel(s) : Hyunju Kang (Kyungpook National University, Republic of Korea), Jun Namkung (Yonsei University, Republic of Korea), Chan Joo Lee (Yonsei University, Republic of Korea)
-
Gut microbiota remodeling in infection and inflammation
Eun-Kyeong Jo Chungnam National University, Republic of Korea 13:00~14:30 -
Ketogenic adaptation to intermittent fasting: implications for nutritional immunometabolism
Kyoung-Han Kim University of Ottawa, Canada 13:20~13:40 -
Spatiotemporal immune activation drives metabolic quiescence in brown adipose tissue
Su Myung Jung Sungkyunkwan University, Republic of Korea 13:40~14:00 - Panel Discussion 14:00~14:30
Chairperson(s) : Chi Dae Kim (Pusan National University, Republic of Korea), Young-Guen Kwon (Young-Guen Kwon, Republic of Korea)
Panel(s) : Yongseek Park (Kyung Hee University, Republic of Korea), Jun Hwan Cho (Chung-Ang University, Republic of Korea), Jae-Hoon Choi (Hanyang University, Republic of Korea)
-
Biobank resources for human metabolic and vascular research
Hyun Joung Lim National Institute of Health, Republic of Korea 13:00~13:20 -
Leveraging biobank platforms to study cardiometabolic physiology and disease
Heiko Bugger Medical University of Graz, Austria 13:20~13:40 -
Integrative analysis of metabolic dysfunction
Young Yang Sookmyung Women\'s University, Republic of Korea 13:40~14:00 - Panel Discussion 14:00~14:30
Chairperson(s) : Young Joon Hong (Chonnam National University, Republic of Korea), Weon Kim (Kyung Hee University, Republic of Korea)
Panel(s) : Ung Kim (Yeungnam University, Republic of Korea), Chang-Hoon Woo (Yeungnam University, Republic of Korea), Jong-Chan Youn (The Catholic University of Korea, Republic of Korea)
-
LDL versus inflammation: what remains after aggressive lipid lowering?
Osung Kwon The Catholic University of Korea, Republic of Korea 13:00~13:18 -
Emerging anti-inflammatory therapies in ASCVD: canakinumab, NLRP3 inhibitors, and beyond
Sung-A Bae Yonsei University, Republic of Korea 13:18~13:36 -
Colchicine for secondary prevention in ASCVD
Dae Young Cheon Hallym University, Republic of Korea 13:36~13:54 -
Immune mechanisms of residual cardiovascular risk: from oxidation-specific epitopes to therapeutic targets
Christoph J. Binder Medical University of Vienna, Austria 13:54~14:12 - Panel Discussion 14:12~14:30
Chairperson(s) : In-Kyung Jeong (Kyung Hee University, Republic of Korea), Hyun Kang (Chung-Ang University, Republic of Korea)
-
Arterial tissue gene expression associated with telomere length attrition in coronary artery disease
Rajkumar Dorajoo Genome Institute of Singapore, Singapore 13:00~13:15 -
Administration of sodium-glucose cotransporter-2 inhibitors following acute myocardial infarction: a systematic review, meta-analysis, and meta-regression of randomized trials
Timotius Ivan Hariyanto Pelita Harapan University, Indonesia 13:15~13:30 -
Sex differences in the diagnosis and treatment for Japanese patients with familial hypercholesterolemia: a retrospective cohort study
Hayato Tada Kanazawa University, Japan 13:30~13:45 -
Tigloylgomisin P inhibits endothelial inflammation by regulating the NF-κB and Smad1/5/9 pathways
Sanguk Yun Inje University, Republic of Korea 13:45~14:00
Chairperson(s) : Hyun Kook (Chonnam National University, Republic of Korea), Jong-Chan Youn (The Catholic University of Korea, Republic of Korea)
-
[OP1-1] Improved survival and in vivo cholesterol-lowering efficacy of microencapsulated Lactobacillus plantarum LAB12
Ismail M. Fareez Universiti Teknologi MARA, Malaysia 14:30~14:40 -
[OP1-2] Lipid accumulation product and visceral adiposity indices as markers of hyperuricemia and gout: a meta-analysis of 575,000 patients
Khalid Sarhan Mansoura University Hospitals, Egypt 14:40~14:50 -
[OP1-3] Distinct vascular targets of metabolic and kidney dysfunction in adults without advanced
Hyo-In Choi Kangbuk Samsung Hospital, Republic of Korea 14:50~15:00 -
[OP1-4] A randomized, double-blind, placebo-controlled, crossover trial to comparatively evaluate the effects of magnesium hydride (MgH2) on endothelial function: a pilot study
Yasuhiro Endo Niigata University of Pharmacy and Medical and Life Sciences, Japan 15:00~15:10 -
[OP1-5] Association of dietary sodium-to-potassium ratio with triglyceride-glucose index and metabolic syndrome risk in Korean adults: using data from the 2022-2023 Korea National Health and Nutrition Examination Survey
Jisu Lee Seoul Women's University, Republic of Korea 15:10~15:20 -
[OP1-6] A newly developed grain-based cereal product for glycemic spike management: effects on glycemic index, glycemic load, and postprandial glucose responses
Soyeon Park Graduate School of Dong-A University, Republic of Korea 15:20~15:30 -
[OP1-7] Nutraceutical modulation of the oral-vascular axis: emerging therapeutic strategies for periodontitis-associated atherosclerosis
Viza Atiq Umar Universitas Islam Sultan Agung, Indonesia 15:30~15:40
Chairperson(s) : Hayato Tada (Kanazawa University, Japan), Sang-Hak Lee (Yonsei University, Republic of Korea)
Panel(s) : Sung Hee Choi (Seoul National University, Republic of Korea)
-
Refined risk assessment in FH
Sayaka Funabashi Kyorin University, Japan 14:30~14:48 - Q&A 14:48~14:52
-
Cause of death in FH
Chan Joo Lee Yonsei University, Republic of Korea 14:52~15:10 - Q&A 15:10~15:14
-
Experience on new drugs for FH: including lomitapide & evinacumab
Hayato Tada Kanazawa University, Japan 15:14~15:32 - Q&A 15:32~15:36
-
Genome editing for precision medicine
HyongBum Kim Yonsei University, Republic of Korea 15:36~15:54 - Q&A 15:54~15:58
Chairperson(s) : Ade Meidian Ambari (University of Indonesia, Indonesia), Ick Mo Chung (Ewha Womans University, Republic of Korea)
Panel(s) : Berlian Idriansyah Idris (EMC Alam Sutera Hospital, Indonesia), Kyung An Kim (The Catholic University of Korea, Republic of Korea), Hyeonju Jeong (Hanyang University, Republic of Korea), Hun Jee Choe (Hallym University, Republic of Korea)
-
The race to the bottom: intensive LDL-C lowering in very high-risk Asian patients
Ade Meidian Ambari University of Indonesia, Indonesia 14:30~14:50 -
Combination therapy in high-risk patients: early vs stepwise approach
Han Na Jung Hallym University, Republic of Korea 14:50~15:10 -
Practical approaches to statin intolerance: from clinical trials to real-world solutions
Jung-Joon Cha Korea University, Republic of Korea 15:10~15:30 - Panel Discussion 15:30~16:00
Chairperson(s) : Geun Sik Hong (Inje University, Republic of Korea), Kwang-Yeol Park (Chung-Ang University, Republic of Korea)
Panel(s) : Bum Joon Kim (University of Ulsan, Republic of Korea), Chi Kyung Kim (Korea University, Republic of Korea), Se-eun Park (Sungkyunkwan University, Republic of Korea)
-
GLP1 RA for stroke prevention
Kang-Ho Choi Chonnam National University, Republic of Korea 14:30~14:50 -
SGLT2 inhibitor for stroke survivors
Jeong-Min Kim Seoul National University, Republic of Korea 14:50~15:10 -
GLP-1 receptor agonists in Alzheimer’s disease
Sang-Won Han Soonchunhyang University, Republic of Korea 15:10~15:30 - Panel Discussion 15:30~16:00
Chairperson(s) : Youngkeun Ahn (Chonnam National University, Republic of Korea), Min Kyong Moon (Seoul National University, Republic of Korea)
Panel(s) : Young Soo Lee (Daegu Catholic University, Republic of Korea), Jun Hwan Cho (Chung-Ang University, Republic of Korea), Sangmo Hong (Hanyang University, Republic of Korea)
-
Choosing the right combination therapy: statin, ezetimibe, PCSK9 inhibitor, or beyond?
Kyung Hoon Cho Chonnam National University, Republic of Korea 16:10~16:28 -
Korean Fact Sheet: Current status of LDL-C control from general population to high-risk groups
Ye Seul Yang Seoul National University, Republic of Korea 16:28~16:46 -
Korean Fact Sheet: Real-world utilization of lipid-lowering agents
Kyuho Kim The Catholic University of Korea, Republic of Korea 16:46~17:04 -
Why are LDL-C targets still unmet? common errors and practical solutions in the clinic
Sang Yeub Lee Chung-Ang University, Republic of Korea 17:04~17:22 - Panel Discussion 17:22~17:40
Chairperson(s) : Sung Rae Kim (The Catholic University of Korea, Republic of Korea), Jae Hyoung Park (Korea University, Republic of Korea)
Panel(s) : Osung Kwon (The Catholic University of Korea, Republic of Korea), Gyu Chul Oh (The Catholic University of Korea, Republic of Korea), Dae Young Cheon (Hallym University, Republic of Korea)
-
Do East Asians need lower statin intensity? ethnic differences in LDL-C response and safety
Eun Jeong Cho Chung-Ang University, Republic of Korea 16:10~16:28 -
Why TG is important in Asians?
Daisaku Masuda Rinku General Medical Center, Japan 16:28~16:46 -
Genetic stratification and treatment response in Korean severe hypertriglyceridemia: a prospective multicenter registry study
Hun Jee Choe Hallym University, Republic of Korea 16:46~17:04 -
Chylomicronemia: past, present and future
Hiroaki Okazaki Teikyo University, Japan 17:04~17:22 - Panel Discussion 17:22~17:40
Chairperson(s) : Eun Gyoung Hong (Hallym University, Republic of Korea), Chul Sik Kim (Yonsei University, Republic of Korea)
Panel(s) : Shinae Kang (Yonsei University, Republic of Korea), JiHyun Ahn (Korea Medical Institute, Republic of Korea), Jung-Joon Cha (Korea University, Republic of Korea)
-
Sex differences in lymphatic function and atherosclerosis outcomes
Catherine Martel University of Montreal, Canada 16:10~16:30 -
Tirzepatide and cardiometabolic outcomes: implications of dual GLP-1/GIP agonism
Yun Kyung Cho University of Ulsan, Republic of Korea 16:30~16:50 -
Effects of SGLT2 inhibitors on lipid metabolism: mechanisms and clinical implications
Jun Hwa Hong Eulji University, Republic of Korea 16:50~17:10 - Panel Discussion 17:10~17:40
Chairperson(s) : Bum Soon Choi (The Catholic University of Korea, Republic of Korea), Sang-Hyun Kim (Seoul National University, Republic of Korea)
Panel(s) : Ji Won Ryu (Seoul National University, Republic of Korea), Eun Hui Bae (Chonnam National University, Republic of Korea)
-
Lipid abnormalities in CKD
Hong Sang Choi Chonnam National University, Republic of Korea 16:10~16:30 -
Why patients with CKD develop accelerated atherosclerosis
Cheol Ho Park Yonsei University, Republic of Korea 16:30~16:50 -
Cardiovascular prevention in CKD: an endocrinologist’s perspective
Eun Roh Seoul National University, Republic of Korea 16:50~17:10 - Panel Discussion 17:10~17:40
Chairperson(s) : Hee-Yeol Kim (Incheon Sejong Hospital, Republic of Korea), Myung-gon Kim (Catholic Kwandong University, Republic of Korea)
Chairperson(s) : Jae Hyoung Park (Korea University, Republic of Korea)
Chairperson(s) : Jeong-Taek Woo (Kyung Hee University, Republic of Korea)
Chairperson(s) : Byung Ryul Cho (Kangwon National University, Republic of Korea), Bong-Ki Lee (Kangwon National University, Republic of Korea)
Chairperson(s) : Jung-Kyu Han (Seoul National University, Republic of Korea), Cheol-Ung Choi (Korea University, Republic of Korea)
-
[OP2-1] Renal lipidomic profiling reveals boerhaavia diffusa extract ameliorates saturated fatty acid lipotoxicity and mitochondrial decay independent of systemic adiposity
Lee On Ying The Hong Kong Polytechnic University, China 08:30~08:40 -
[OP2-2] Extrahepatic bile acid synthesis reprograms multiorgan cholesterol flux in cardiovascular disease
Hosung Bae University of Iowa, United States 08:40~08:50 -
[OP2-3] Prdx3 deficiency triggers cGAS-STING signaling pathway induced vascular smooth muscle cell senescence and phenotypic switching in abdominal aortic aneurysm
Moajury Jung Ewha Womans University, Republic of Korea 08:50~09:00 -
[OP2-4] Sphingosine-1-phosphate receptor 1 deletion in smooth muscle cells protects against atherosclerosis in apoE-deficient mice by reducing lipid droplet formation
Bernardo Trigatti Hamilton Health Sciences, Canada 09:00~09:10 -
[OP2-5] Senolytic therapy attenuates atherosclerosis and metabolic dysfunction by targeting cellular senescence in western diet-fed Ldlr KO mice
Hye Rang Park Korea Research Institute of Bioscience and Biotechnology (KRIBB), Republic of Korea 09:10~09:20 -
[OP2-6] The role of LGI3 in adipocytes and macrophages in atherosclerosis
Do Hee Yu Department of Life Sciences, Ewha Womans University, Republic of Korea 09:20~09:30 -
[OP2-7] Cyclic induction of OSKM expression mitigates atherosclerosis through vascular anti-inflammatory remodeling independent of systemic metabolic effects
Young Hoon Seo Korea Research Institute of Bioscience and Biotechnology (KRIBB), Republic of Korea 09:30~09:40 -
[OP2-8] Extracellular vesicles produced by M2-polarized macrophages drive atherosclerosis regression by reprograming Ly-6Chi monocytes & enhancing efferocytosis
Robert L. Raffai University of California, San Francisco, United States 09:40~09:50
Chairperson(s) : Sungha Park (Yonsei University, Republic of Korea), Sang-Hak Lee (Yonsei University, Republic of Korea)
Panel(s) : Gyu Chul Oh (The Catholic University of Korea, Republic of Korea), Ji-Yong Jang (National Health Insurance Service Ilsan Hospital, Republic of Korea), Yun Kyung Cho (University of Ulsan, Republic of Korea)
-
Bempedoic acid: LDL-C lowering beyond statins - evidence and clinical role
Chewan Lim Catholic Kwandong University, Republic of Korea 08:30~08:50 -
Optimizing non-statin therapy: PCSK9 inhibitors and inclisiran
Kyung-Hee Kim Incheon Sejong Hospital, Republic of Korea 08:50~09:10 -
Emerging Lp(a)-lowering therapies: siRNA, ASO, and beyond
Yu-Chen Wang Asia University, Taiwan 09:10~09:30 - Panel Discussion 09:30~10:00
Chairperson(s) : Jung-Sun Kim (Yonsei University, Republic of Korea), Junghyun Noh (Inje University, Republic of Korea)
Panel(s) : Sang Yong Kim (Chosun University, Republic of Korea), Ji Woong Yoo (Hallym University, Republic of Korea), Mi-Hyang Jung (The Catholic University of Korea, Republic of Korea)
-
Lipid-lowering therapy in people living with HIV (PLWH)
So Ree Kim Korea University, Republic of Korea 08:30~08:48 -
Lipid-lowering therapy in cancer patients and survivors
Hiroshi Akazawa Kanazawa Medical University, Japan 08:48~09:06 -
Lipid-lowering therapy in patients with CKD
Eun Sil Koh The Catholic University of Korea, Republic of Korea 09:06~09:24 -
Cardiovascular prevention in hemodialysis: is omega-3 back?
Sang Ho Jo Hallym University, Republic of Korea 09:24~09:42 - Panel Discussion 09:42~10:00
Chairperson(s) : Yong Sook Kim (Chonnam National University, Republic of Korea), Hyeong-Gyu Kim (Inje University, Republic of Korea)
Panel(s) : Nari Kim (Inje University, Republic of Korea), Jong-Gil Park (Korea Research Institute of Bioscience and Biotechnology, Republic of Korea), Dong Kyu Choi (Kyungpook National University, Republic of Korea)
-
Ion channels in atherosclerosis: from calcium flux to vascular dysfunction
Sung Joon Kim Seoul National University, Republic of Korea 08:30~08:50 -
Energy metabolism and lipid oxidation in cardiometabolic pathophysiology
Jin Han Inje University, Republic of Korea 08:50~09:10 -
Lp(a): from lipoprotein biology to atherosclerotic cardiovascular disease
Jung-Woo Son Yonsei University, Republic of Korea 09:10~09:30 - Panel Discussion 09:30~10:00
Chairperson(s) : Sung Rae Kim (The Catholic University of Korea, Republic of Korea)
Chairperson(s) : TBD (Affiliation, Country)
Chairperson(s) : Young-Bae Park (Seoul National University, Republic of Korea)
-
Start early: upfront combination therapy for faster LDL-C goal attainment in the CKM era
Soo-Jin Kim Kosin University, Republic of Korea 11:45~12:00 -
Start strong: elevating LDL-C management in ASCVD with high-dose atorvastatin plus ezetimibe
Jeehoon Kang Seoul National University, Republic of Korea 12:00~12:15
Chairperson(s) : Kyong Soo Park (Konkuk University, Republic of Korea), Myung A Kim (Seoul National University, Republic of Korea)
Chairperson(s) : Hyo-Soo Kim (Seoul National University, Republic of Korea)
Chairperson(s) : Moon-Kyu Lee (Eulji University, Republic of Korea)
Chairperson(s) : Hyun Ho Shin (Asan Chungmu Hospital, Republic of Korea)
Chairperson(s) : Sung Rae Kim (The Catholic University of Korea, Republic of Korea), Sang-Hyun Kim (Seoul National University, Republic of Korea)
- 2026 KSoLA Award Ceremony for Scientific Excellence & Young Investigator 12:45~12:50
-
The quiet signal, no longer - triglyceride at the crossroads of insulin resistance and cardiometabolic risk
Cheol-Young Park Sungkyunkwan University, Republic of Korea 12:50~13:10 - Q&A 13:10~13:15
-
The health information on social media: the reliability and professionals’ responsibility
Il Hak Lee Yonsei University, Republic of Korea 13:15~13:35 - Q&A 13:35~13:40
Chairperson(s) : Mi-Seung Shin (Gachon University, Republic of Korea), Jun-Hee Lee (Hallym University, Republic of Korea)
Panel(s) : Hack-Lyoung Kim (Seoul National University, Republic of Korea), Ye Seul Yang (Seoul National University, Republic of Korea), Seok Oh (Chonnam National University, Republic of Korea)
-
Sex differences in lipids and lipoproteins and residual cardiovascular risk: beyond LDL cholesterol
Soo-Jin Kim Kosin University, Republic of Korea 12:45~13:00 -
Early-onset dyslipidemia in young adults: screening strategies and lifetime ASCVD risk assessment
Jaehyun Bae Hallym University, Republic of Korea 13:00~13:15 -
Menopause and cardiometabolic transition: optimizing lipid management in midlife women
In Jeong Cho Ewha Womans University, Republic of Korea 13:15~13:30 - Panel Discussion 13:30~13:45
Chairperson(s) : Sang-Hyun Kim (Seoul National University, Republic of Korea), Woo Je Lee (University of Ulsan, Republic of Korea)
Panel(s) : Eunju Park (Kyungnam University, Republic of Korea), Jee Hee Yoo (Chung-Ang University, Republic of Korea), Hye Moon Chung (Kyung Hee University, Republic of Korea)
-
Korean epidemiology and risk modifiers for establishing LDL-C goal strategies
Jong Han Choi Konkuk University, Republic of Korea 13:45~14:03 -
Practical algorithm for intensive lipid lowering therapy in the 2026 Korean guidelines
Jaehoon Chung Gachon University, Republic of Korea 14:03~14:21 -
Nutritional management and lifestyle modification tailored to the Korean dietary pattern
Garam Jo Hannam University, Republic of Korea 14:21~14:39 -
Optimized lipid management for special populations
Byung Sik Kim Hanyang University, Republic of Korea 14:39~14:57 - Panel Discussion 14:57~15:15
Chairperson(s) : Donghoon Choi (Yonsei University, Republic of Korea), Kyung Woo Park (Seoul National University, Republic of Korea)
Panel(s) : Jaehyun Bae (Hallym University, Republic of Korea), Heung Yong Jin (Jeonbuk National University, Republic of Korea), Jung-Kyu Han (Seoul National University, Republic of Korea)
-
Lipoprotein(a) in Korean patients: real-world data, cardiovascular risk, and clinical implications
Sang Min Park Eulji University, Republic of Korea 13:45~14:05 -
Lipoprotein(a) and coronary atherosclerosis in Vietnam: real-world data and emerging cardiovascular risk
Anh Tien Hoang Hue University, Vietnam 14:05~14:25 -
Measuring Lipoprotein(a) in clinical practice: assay challenges, standardization, and interpretation
Sang-Guk Lee Yonsei University, Republic of Korea 14:25~14:45 - Panel Discussion 14:45~15:15
Chairperson(s) : Jung Rae Cho (Hallym University, Republic of Korea), Byung Jin Kim (Sungkyunkwan University, Republic of Korea)
Panel(s) : Bom Lee (CHA University, Republic of Korea), Hyun Sung Joh (Seoul National University, Republic of Korea), Hyung Joon Joo (Korea University, Republic of Korea)
-
Evolution of vulnerable plaques: from natural history to preventive intervention
Jin Ho Lee Kyung Hee University, Republic of Korea 13:45~14:03 -
High-risk plaque features on CCTA: identification and clinical implications
Sang Yoon Lee Sungkyunkwan University, Republic of Korea 14:03~14:21 -
Intravascular imaging of vulnerable plaques: insights from IVUS and OCT
Ju Hyeon Kim University of Ulsan, Republic of Korea 14:21~14:39 -
Coronary physiology and plaque vulnerability: integrative relationship and prognostic implications
Seok Hun Yang Seoul National University, Republic of Korea 14:39~14:57 - Panel Discussion 14:57~15:15
Chairperson(s) : Seok-Min Kang (Yonsei University, Republic of Korea), Ki Chul Sung (Sungkyunkwan University, Republic of Korea)
Panel(s) : Bo Kyung Koo (Seoul National University, Republic of Korea), Kyung-Jin Kim (Ewha Womans University, Republic of Korea), Heesun Lee (Seoul National University, Republic of Korea)
-
Fatty liver and residual cardiovascular risk: epidemiology and clinical implications
Eun Jung Rhee Sungkyunkwan University, Republic of Korea 13:45~14:05 -
From lipotoxicity to atherosclerosis: MASLD/MetALD subtypes and cardiovascular risk - a hepatologist’s perspective
Su Jong Yu Seoul National University, Republic of Korea 14:05~14:25 -
Therapeutic strategies for cardiometabolic risk reduction in MASLD
Toru Miyoshi Okayama University, Japan 14:25~14:45 - Panel Discussion 14:45~15:15
Chairperson(s) : Woo Je Lee (University of Ulsan, Republic of Korea)
Chairperson(s) : Sang-Hyun Lim (The Catholic University of Korea, Republic of Korea), Eung Gyu Kim (Inje University, Republic of Korea)
Panel(s) : Hyung-Min Kwon (Seoul National University, Republic of Korea), Minjeong Kim (Ewha Womans University, Republic of Korea), Garam Cho (Hannam University, Republic of Korea)
-
PCSK9 inhibition in primary prevention: insights from VESALIUS-CV and clinical implications
Doo Sun Sim Chonnam National University, Republic of Korea 16:10~16:30 -
Low LDL-C and brain safety: risk of hemorrhagic stroke and cognitive dysfunction
Kwang-Yeol Park Chung-Ang University, Republic of Korea 16:30~16:50 -
Early combination therapy in primary prevention
Hoyoun Won Chung-Ang University, Republic of Korea 16:50~17:10 - Panel Discussion 17:10~17:40
Chairperson(s) : Sang Yup Lim (Korea University, Republic of Korea)
Panel(s) : Byung Sik Kim (Hanyang University, Republic of Korea), Eun Jung Rhee (Sungkyunkwan University, Republic of Korea), Jang Hoon Lee (Kyungpook National University, Republic of Korea)
-
CETP inhibition revisited: obicetrapib for LDL-C reduction and ASCVD risk management
Mariko Harada-Shiba Osaka Medical and Pharmaceutical University, Japan 16:10~16:30 -
APOC3 inhibition: targeting triglyceride-rich lipoproteins and residual risk
Jin Wi Gachon University, Republic of Korea 16:30~16:50 -
ANGPTL3 inhibition: expanding therapeutic opportunities beyond LDL-C
Hye Moon Chung Kyung Hee University, Republic of Korea 16:50~17:10 - Panel Discussion 17:10~17:40
Chairperson(s) : Seung Woo Park (Sungkyunkwan University, Republic of Korea), Young-Hoon Jeong (Chung-Ang University, Republic of Korea)
Panel(s) : Jaehyun Bae (Hallym University, Republic of Korea), Jung Myung Lee (Sahmyook Medical Center, Republic of Korea), Jong Han Choi (Konkuk University, Republic of Korea), Jong Han Choi (Konkuk University, Republic of Korea)
-
Defining residual cardiovascular risk in the post-LDL era: unmet needs and mechanisms
Hyung Joon Joo Korea University, Republic of Korea 16:10~16:30 -
Targeting residual risk: Lp(a), triglyceride-rich lipoproteins, and inflammation
Sung Gyun Ahn Yonsei University, Republic of Korea 16:30~16:50 -
Beyond less is more: navigating residual thrombotic and inflammatory risk in AF and stable CAD
Satoshi Yasuda Tohoku University, Japan 16:50~17:10 - Panel Discussion 17:10~17:40
Chairperson(s) : Min Sun Kim (University of Ulsan, Republic of Korea), In-Kyung Jeong (Kyung Hee University, Republic of Korea)
Panel(s) : Song-Yi Kim (Jeju National University, Republic of Korea), Jee Hee Yoo (Chung-Ang University, Republic of Korea), Heung Yong Jin (Jeonbuk National University, Republic of Korea)
-
Lipid remodeling of adipose tissue: the hidden link between obesity and atherosclerosis
Yun-Hee Lee Seoul National University, Republic of Korea 16:10~16:30 -
Remnant cholesterol and residual cardiovascular risk in obesity
Young-Sang Lyu Chosun University, Republic of Korea 16:30~16:50 -
Dual targeting of lipid and weight: emerging therapies and clinical strategies
Chang Hee Jung University of Ulsan, Republic of Korea 16:50~17:10 - Panel Discussion 17:10~17:40
Chairperson(s) : Myung Ho Jeong (Gwangju Veterans Hospital, Republic of Korea)
Chairperson(s) : Kwang-Won Kim (Gachon University, Republic of Korea), Kwang Kon Koh (Gachon University, Republic of Korea)
Chairperson(s) : Sang-Wook Lim (Cha University, Republic of Korea)
Chairperson(s) : Soon Jun Hong (Korea University, Republic of Korea), Shung Chull Chae (Kyungpook National University, Republic of Korea)
-
Integrated lipid management across the CKM spectrum: from evidence to practice
Jong-Chan Youn The Catholic University of Korea, Republic of Korea 07:50~08:02 -
The importance of preventing infectious diseases and shingles in patient with underlying medical conditions
Timothy C. Tan Western Sydney University, Australia 08:02~08:14 -
Why is LDL-C control still insufficient? finding the breakthrough with leqvio cases in the aLLT era
Jung-Joon Cha Korea University, Republic of Korea 08:14~08:26
Chairperson(s) : Hyeong Kyu Park (Soonchunhyang University, Republic of Korea), Han-Mo Yang (Seoul National University, Republic of Korea)
-
[OP3-1] Residual risk of remnant cholesterol in patients treated to LDL-C goal: a landmark analysis of the RACING trial
Sungyeon Park Yonsei University Wonju College of Medicine, Republic of Korea 08:50~09:00 -
[OP3-2] Lower cardiovascular event risk with bempedoic acid versus ezetimibe in statin-intolerant atherosclerotic cardiovascular disease (ASCVD): a 3,540-patient TriNetX analysis
Ahmed Elaraby Faculty of medicine, Al-Azhar University, Egypt 09:00~09:10 -
[OP3-3] Age-dependent association of atherogenic dyslipidemia with incident cardiovascular disease: a nationwide Korean cohort study
Ye Seul Yang Seoul National University College of Medicine, Republic of Korea 09:10~09:20 -
[OP3-4] Deep learning analysis of BMI, metabolic risk factors, and sex hormones in U.S. women: a NHANES study
Saheed Oladele Amusat Beaumont Hospital, Ireland 09:20~09:30 -
[OP3-5] Prevalence of high inflammatory risk in atherosclerotic cardiovascular disease with and without chronic kidney disease: findings from POSEIDON - a global cross-sectional prevalence study
Kyungsoo Won Novo Nordisk Korea, Republic of Korea 09:30~09:40 -
[OP3-6] Real-world efficacy and tolerability of inclisiran in Malaysian patients with atherosclerotic cardiovascular disease: a single-centre experience
Kim Fong Ng KPJ Kluang Specialist Hospital, Malaysia 09:40~09:50 -
[OP3-7] A Korean multidimensional social determinants of health index identifies individuals at elevated risk of severe coronary artery calcification: evidence from the CMERC cohort
Jooeun Jeon Ewha Womans University Mokdong Hospital, Republic of Korea 09:50~10:00 -
[OP3-8] Efficacy and safety of enlicitide decanoate, an oral macrocyclic peptide inhibitor of PCSK9, compared with bempedoic acid, ezetimibe, or bempedoic acid co-administered with ezetimibe in statin-treated adults with hypercholesterolemia: phase 3 CORALreef AddOn trial
Maria Carolina Emilia Villanueva MSD Philippines, Republic of Korea 10:00~10:10
Chairperson(s) : Chin-Chou Huang (Taipei Veterans General Hospital, Taiwan)
Panel(s) : Young Sang Lyu (Chosun University, Republic of Korea), Hong Seok Lim (Ajou University, Republic of Korea), Hansaem Jung (Jeong Hansaem Internal Medicine Clinic, Republic of Korea)
-
The emerging role of ApoB and triglyceride-rich lipoproteins
Sin Yung Woo Konyang University, Republic of Korea 08:50~09:10 -
Beyond LDL-C: targeting inflammation and lipoprotein(a) to address residual cardiovascular risk in Asia
Ping-Yen Liu National Cheng Kung University, Taiwan 09:10~09:30 -
Cardiometabolic residual risk in Asia: diabetes, metabolic dysfunction, and vascular aging
Minkwan Kim Yonsei University, Republic of Korea 09:30~09:50 - Panel Discussion 09:50~10:20
Chairperson(s) : Donghoon Choi (Yonsei University, Republic of Korea), Keeho Song (Konkuk University, Republic of Korea)
Panel(s) : Eu Jeong Ku (Seoul National University, Republic of Korea), Young Sup Byun (Inje University, Republic of Korea), Jang Hoon Lee (Kyungpook National University, Republic of Korea)
-
Oxidized phospholipids on lipoprotein(a): a key driver of atherothrombosis?
Sotirios Tsimikas University of California, San Diego, USA 08:50~09:10 -
Does lipoprotein(a) promote thrombosis? evidence from genetics and population studies
Borge G. Nordestgaard University of Copenhagen, Denmark 09:10~09:30 -
Epidemiology and cardiovascular events: what have we learned?
Sang-Rok Lee Jeonbuk National University, Republic of Korea 09:30~09:50 - Panel Discussion 09:50~10:20
Chairperson(s) : Hack-Lyoung Kim (Seoul National University, Republic of Korea)
Panel(s) : Ji Hyun Kim (The Catholic University of Korea, Republic of Korea), Joon Ho Moon (Seoul National University, Republic of Korea), Junghwan Park (Hanyang University, Republic of Korea)
-
Dyslipidemia across ethnicities in Malaysia: who is at risk, and who is being left behind?
Nor Ashikin Md Sari University of Malaya, Malaysia 08:50~09:10 -
Genetic architecture of dyslipidemia and cardiovascular risk in East Asians: from monogenic variants to polygenic risk
Soo Heon Kwak Seoul National University, Republic of Korea 09:10~09:30 -
Epidemiological trends of dyslipidemia in Korea and their implications for Asian populations
Hokyou Lee Yonsei University, Republic of Korea 09:30~09:50 - Panel Discussion 09:50~10:20
Chairperson(s) : Sang-Hyun Kim (Seoul National University, Republic of Korea)
Chairperson(s) : Ick Mo Chung (Ewha Womans University, Republic of Korea)
Chairperson(s) : Sang Hong Baek (The Catholic University of Korea, Republic of Korea)
Chairperson(s) : Hong Seog Seo (Korea University, Republic of Korea)
Chairperson(s) : Hak Chul Jang (Seoul National University, Republic of Korea)
Chairperson(s) : Kwang-il Kim (Seoul National University, Republic of Korea), Jun Hwa Hong (Eulji University, Republic of Korea)
Panel(s) : Eu Jeong Ku (Seoul National University, Republic of Korea), Hyo-Suk Ahn (The Catholic University of Korea, Republic of Korea), Han-Mo Yang (Seoul National University, Republic of Korea)
-
Residual cardiovascular risk in hypertension despite optimal BP control
Hyue Mee Kim Chung-Ang University, Republic of Korea 13:00~13:15 -
Lipid management in hypertensive patients
Jaehoon Chung Gachon University, Republic of Korea 13:15~13:30 -
Obesity, insulin resistance, and hypertension-related vascular injury
Mihye Seo Soonchunhyang University, Republic of Korea 13:30~13:45 - Panel Discussion 13:45~14:00
Chairperson(s) : Joon Hyung Doh (Inje University, Republic of Korea), Sang Yeub Lee (Chung-Ang University, Republic of Korea)
Panel(s) : Yong Hyun Park (Pusan National University, Republic of Korea), Hyun-Woong Park (Chungnam National University, Republic of Korea), Jong Shin Woo (Kyung Hee University, Republic of Korea), Soo Young Lee (Chung-Ang University, Republic of Korea)
-
Impact of lipid-lowering therapy on plaque stabilization and regression
Jong Young Lee Hallym University, Republic of Korea 13:00~13:15 -
Coronary microvascular dysfunction after PCI
Hyun Sung Joh Seoul National University, Republic of Korea 13:15~13:30 -
Discordance between CAC and coronary stenosis
Sang Hoon Shin Ewha Womans University, Republic of Korea 13:30~13:45 - Panel Discussion 13:45~14:00
Chairperson(s) : Sung Rae Kim (The Catholic University of Korea, Republic of Korea), Hyuk-Sang Kwon (The Catholic University of Korea, Republic of Korea)
Panel(s) : Joon Ho Moon (Seoul National University, Republic of Korea), Ki-Hyun Jeon (Seoul National University, Republic of Korea), A Ram Hong (Chonnam National University, Republic of Korea)
-
Hypertriglyceridemia and remnant cholesterol in diabetes
Sung Hee Choi Seoul National University, Republic of Korea 13:00~13:15 -
Arterial stiffness and vascular aging in diabetes
Hack-Lyoung Kim Seoul National University, Republic of Korea 13:15~13:30 -
Coronary artery calcium and subclinical atherosclerosis in diabetes
Jang Hoon Lee Kyungpook National University, Republic of Korea 13:30~13:45 - Panel Discussion 13:45~14:00
Chairperson(s) : TBD (Affiliation, Country)
Chairperson(s) : Yong-Jae Kim (Kim's Neurology Clinic, Republic of Korea), Sung Kee Ryu (Ewha Womans University, Republic of Korea)
Panel(s) : Jaeseok Kim (Yonsei University, Republic of Korea), Min Kyung Lee (Hanyang University, Republic of Korea), Min-Ho Lee (Sahmyook Medical Center, Republic of Korea)
-
Cardiologist perspective: implementing novel cardiometabolic therapies in CVD
Donna Shu-Han Lin Shin Kong Wu Ho-Su Memorial Hospital, Taiwan 14:10~14:30 -
Nephrologist’s perspective: kidney protection strategies to improve cardio-kidney outcomes
Jong Hyun Jhee Yonsei University, Republic of Korea 14:30~14:50 -
Endocrinologist perspective: optimizing combination therapy in complex CKM patients
Jae-Seung Yun The Catholic University of Korea, Republic of Korea 14:50~15:10 - Panel Discussion 15:10~15:40
Chairperson(s) : Yongseek Park (Kyung Hee University, Republic of Korea), Hyun Jae Kang (Seoul National University, Republic of Korea)
Panel(s) : Kyu-Yong Ko (Inje University, Republic of Korea), Hee-Dong Kim (Soonchunhyang University, Republic of Korea), Kwan Yong Lee (The Catholic University of Korea, Republic of Korea)
-
AI-CVD: opportunistic testing of coronary calcium and beyond
Nathan D. Wong University of California, Irvine, USA 14:10~14:28 -
A+4DCT: angio enhanced dynamic CT for non-invasive functional diagnosis of coronary artery disease
Joon Sang Lee Yonsei University, Republic of Korea 14:28~14:46 -
Application of AI to coronary angiography
Si-Hyuck Kang Seoul National University, Republic of Korea 14:46~15:04 -
AI-based retinomics: cardiovascular risk prediction using retinal imaging
Sahil Thakur Medical Affairs, Mediwhale Inc., Singapore 15:04~15:22 - Panel Discussion 15:22~15:40
Chairperson(s) : Bon-kwon Koo (Seoul National University, Republic of Korea), Eun Jung Rhee (Sungkyunkwan University, Republic of Korea)
Panel(s) : Mihye Seo (Soonchunhyang University, Republic of Korea), Hyun Ju You (Seoul National University, Republic of Korea), Jun Hwa Hong (Eulji University, Republic of Korea)
-
Lipid management in primary prevention: who, when, and how aggressive?
Yeoree Yang The Catholic University of Korea, Republic of Korea 14:10~14:30 -
Every minute counts: exercise snacks for better health and life’s essential 8
SoJung Lee Kyung Hee University, Republic of Korea 14:30~14:50 -
Advancing cardiovascular management through vaccination
Jae Hyoung Park Korea University, Republic of Korea 14:50~15:10 - Panel Discussion 15:10~15:40
Chairperson(s) : Sung Hee Choi (Seoul National University, Republic of Korea), Sun Wook Cho (Seoul National University, Republic of Korea)
Panel(s) : Dae-Young Kim (Inha University, Republic of Korea), Seo Young Sohn (Inje University, Republic of Korea), You-Bin Lee (Sungkyunkwan University, Republic of Korea)
-
Diabetic dyslipidemia: targeting residual risk beyond LDL-C lowering
Kyung-Soo Kim CHA University, Republic of Korea 14:10~14:30 -
Subclinical thyroid dysfunction: when should we treat for cardiovascular and metabolic health?
Eu Jeong Ku Seoul National University, Republic of Korea 14:30~14:50 -
Atherogenic dyslipidemia in women: PCOS, menopause, and cardiovascular risk
Jeong Rang Park Gyeongsang National University, Republic of Korea 14:50~15:10 - Panel Discussion 15:10~15:40
Chairperson(s) : Yang Ha Kim (Ewha Womans University, Republic of Korea), Min-Jeong Shin (Korea University, Republic of Korea)
Panel(s) : Mogan Gim (Hankuk University of Foreign Studies, Republic of Korea), Jeong-Min Kim (Seoul National University, Republic of Korea), Seung-Hwan Lee (The Catholic University of Korea, Republic of Korea)
-
Dietary and social determinants of the human microbiome: implications for metabolic health
So Young Kwak Kyungpook National University, Republic of Korea 15:40~16:00 -
Understanding gene-diet interactions in cardiometabolic health: genetic risk scores and their modification by diet in Korean and UK biobank cohorts
Sunmin Park Hoseo University, Republic of Korea 16:00~16:20 -
Interaction effects of genetic variants and dietary intake on the development of metabolic syndrome
Dayeon Shin Ewha Womans University, Republic of Korea 16:20~16:40 - Panel Discussion 16:40~17:10
Chairperson(s) : Borge G. Nordestgaard (University of Copenhagen, Denmark), Cheol-Young Park (Sungkyunkwan University, Republic of Korea)
Panel(s) : Seon Mee Kang (Soonchunhyang University, Republic of Korea), Min Kyung Lee (Hanyang University, Republic of Korea), Ji Eun Lee (Korea University, Republic of Korea)
-
ESC/EAS dyslipidemia guidelines: recent updates and evidence base
Meral Kayikcioglu Ege University, Türkiye 15:40~16:00 -
Korean perspectives on dyslipidemia guidelines: recent update and challenges
Jaehoon Chung Gachon University, Republic of Korea 16:00~16:20 -
Translating guidelines into practice
Wonjin Kim CHA University, Republic of Korea 16:20~16:40 - Panel Discussion 16:40~17:10
Chairperson(s) : Goo Taeg Oh (Ewha Womans University, Republic of Korea), Young Mi Park (Ewha Womans University, Republic of Korea)
Panel(s) : Yoo-Wook Kwon (Seoul National University, Republic of Korea), Hyue Mee Kim (Chung-Ang University, Republic of Korea), Kyung-Sun Heo (Chungnam National University, Republic of Korea)
-
Non-inflammatory function of dendritic cell in the regulation of obesity-associated heart failure
Kae Won Cho Soonchunhyang University, Republic of Korea 15:40~16:00 -
Hepatic lipotoxicity and fibrotic remodeling in metabolic liver disease
KyeongJin Kim Inha University, Republic of Korea 16:00~16:20 -
From lipidomics to systems biology: decoding metabolic networks
Guanghou Shui Chinese Academy of Sciences, China 16:20~16:40 - Panel Discussion 16:40~17:10
Chairperson(s) : Sun Ha Jee (Yonsei University, Republic of Korea), Oh-Yoen Kim (Dong-A University, Republic of Korea)
Panel(s) : Si-Hyuck Kang (Seoul National University, Republic of Korea), Jong Young Lee (Hallym University, Republic of Korea), Jun Young Hong (Yonsei University, Republic of Korea)
-
Air pollution and cardiovascular disease
Sera Kim Korea Environment Institute, Republic of Korea 15:40~16:00 -
Microplastics and cardiovascular health: current epidemiological evidence and challenges
Dong-Wook Lee Seoul National University, Republic of Korea 16:00~16:20 -
Climate change and cardiometabolic disease
Whan Hee Lee Pusan National University, Republic of Korea 16:20~16:40 - Panel Discussion 16:40~17:10
